Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8528097 | Clinical Therapeutics | 2018 | 9 Pages |
Abstract
Older patients experience the highest risk for lung cancer incidence and mortality, and stand to be the most likely to benefit from lung cancer screening. However, careful consideration must be given to higher rates of false-positives and overdiagnosis in this population, as well as tolerability of surgery and competing risks for death from other causes. The appropriate selection of older individuals for lung cancer screening can be greatly optimized by using validated risk-based targeting.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Meytal S. MD, Juan P. MD, DrPH, Thomas MD, PhD, Emanuela MD, PhD, Rajwanth R. MD, MSCR,